$15.06
0.20% yesterday
Nasdaq, Sep 03, 10:00 pm CET
ISIN
KYG011251066
Symbol
AFYA

Afya Stock price

$15.06
+0.80 5.61% 1M
-1.39 8.45% 6M
-0.82 5.16% YTD
-1.46 8.84% 1Y
+2.00 15.31% 3Y
-10.20 40.38% 5Y
-9.03 37.48% 10Y
-9.03 37.48% 20Y
Nasdaq, Closing price Wed, Sep 03 2025
+0.03 0.20%
ISIN
KYG011251066
Symbol
AFYA

Key metrics

Basic
Market capitalization
$1.4b
Enterprise Value
$1.8b
Net debt
$390.0m
Cash
$201.6m
Shares outstanding
93.7m
Valuation (TTM | estimate)
P/E
10.8 | 8.6
P/S
2.1 | 2.0
EV/Sales
2.7 | 2.5
EV/FCF
8.7
P/B
1.6
Financial Health
Equity Ratio
48.4%
Return on Equity
14.8%
ROCE
15.9%
ROIC
14.4%
Debt/Equity
0.7
Financials (TTM | estimate)
Revenue
$650.5m | $697.4m
EBITDA
$276.3m | $308.2m
EBIT
$210.9m | $233.9m
Net Income
$127.4m | $163.7m
Free Cash Flow
$201.2m
Growth (TTM | estimate)
Revenue
15.6% | 15.1%
EBITDA
26.0% | 24.9%
EBIT
30.5% | 26.0%
Net Income
25.5% | 41.3%
Free Cash Flow
22.8%
Margin (TTM | estimate)
Gross
64.6%
EBITDA
42.5% | 44.2%
EBIT
32.4%
Net
19.6% | 23.5%
Free Cash Flow
30.9%
More
EPS
$1.4
FCF per Share
$2.1
Short interest
1.6%
Employees
5k
Rev per Employee
$120.0k
Show more

Is Afya a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Afya Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Afya forecast:

8x Buy
57%
5x Hold
36%
1x Sell
7%

Analyst Opinions

14 Analysts have issued a Afya forecast:

Buy
57%
Hold
36%
Sell
7%

Financial data from Afya

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
650 650
16% 16%
100%
- Direct Costs 231 231
8% 8%
35%
420 420
20% 20%
65%
- Selling and Administrative Expenses 209 209
10% 10%
32%
- Research and Development Expense - -
-
-
276 276
26% 26%
42%
- Depreciation and Amortization 65 65
13% 13%
10%
EBIT (Operating Income) EBIT 211 211
30% 30%
32%
Net Profit 127 127
26% 26%
20%

In millions USD.

Don't miss a Thing! We will send you all news about Afya directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Afya Stock News

Positive
Seeking Alpha
19 days ago
Afya's Q2 2025 results were solid, but the stock faces headwinds from market saturation and regulatory changes in Brazil's medical education sector. Valuation is now more attractive after a 20%+ price drop, but risks from lower pricing power, increased competition, and new quality exams remain significant. The company is shifting capital allocation toward buybacks and dividends, signaling fewer...
Neutral
Seeking Alpha
21 days ago
Afya Limited (NASDAQ:AFYA ) Q2 2025 Earnings Conference Call August 13, 2025 5:00 PM ET Company Participants Luis Andre Carpintero Blanco - Chief Financial Officer Virgilio Deloy Capobianco Gibbon - Chief Executive Officer Conference Call Participants Flavio Yoshida - BofA Securities, Research Division Lucca Generali Marquezini - Itaú Corretora de Valores S.A., Research Division Marcelo Peev do...
Neutral
Business Wire
22 days ago
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2025 (second quarter 2025). Financial results are expressed in Brazilian Reais and are present...
More Afya News

Company Profile

Afya Ltd. is a medical education group in Brazil. It delivers an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs and continuing medical education activities. The company operates through the following two segments: Education Services and Residency Preparatory & Specialization Programs. The Education Services segment provides educational services through undergraduate and graduate courses related to medicine, other health sciences and other undergraduate programs. The Residency Preparatory & Specialization Programs segment provides residency preparatory courses and medical post-graduate specialization programs, delivering printed and digital content, an online medical education platform and practical medical training. Afya was founded on March 22, 2019 and is headquartered in Nova Lima, Brazil.

Head office Cayman Islands
CEO Mr. Gibbon
Employees 5,260
Founded 2019
Website www.afya.com.br

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today